Charles Schwab Investment Management Inc. Acquires 151,434 Shares of MEDIFAST INC $MED

Charles Schwab Investment Management Inc. lifted its holdings in MEDIFAST INC (NYSE:MED) by 132.7% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 265,572 shares of the specialty retailer’s stock after buying an additional 151,434 shares during the period. Charles Schwab Investment Management Inc. owned about 2.42% of MEDIFAST worth $3,580,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Wells Fargo & Company MN boosted its position in MEDIFAST by 23.5% in the 4th quarter. Wells Fargo & Company MN now owns 6,459 shares of the specialty retailer’s stock valued at $114,000 after buying an additional 1,227 shares during the period. Barclays PLC boosted its position in MEDIFAST by 15.1% in the 4th quarter. Barclays PLC now owns 16,194 shares of the specialty retailer’s stock valued at $285,000 after buying an additional 2,127 shares during the period. Northern Trust Corp boosted its position in MEDIFAST by 0.9% in the 4th quarter. Northern Trust Corp now owns 101,775 shares of the specialty retailer’s stock valued at $1,793,000 after buying an additional 871 shares during the period. Bridgeway Capital Management LLC purchased a new stake in MEDIFAST in the 4th quarter valued at about $352,000. Finally, Deutsche Bank AG boosted its position in MEDIFAST by 10.4% in the 4th quarter. Deutsche Bank AG now owns 29,553 shares of the specialty retailer’s stock valued at $521,000 after buying an additional 2,787 shares during the period. 95.51% of the stock is currently owned by institutional investors.

MEDIFAST Price Performance

MEDIFAST stock opened at $14.06 on Friday. The stock has a market cap of $154.52 million, a price-to-earnings ratio of 43.94 and a beta of 0.80. MEDIFAST INC has a 1 year low of $11.57 and a 1 year high of $21.98. The firm has a 50-day moving average of $13.93 and a two-hundred day moving average of $13.70.

MEDIFAST (NYSE:MED) last released its quarterly earnings data on Monday, August 4th. The specialty retailer reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.26. The company had revenue of $105.56 million during the quarter, compared to analysts’ expectations of $96.10 million. MEDIFAST had a net margin of 0.76% and a return on equity of 2.00%. MEDIFAST has set its Q3 2025 guidance at -0.600-0.00 EPS. Research analysts expect that MEDIFAST INC will post 0.51 earnings per share for the current year.

About MEDIFAST

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.